BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34537861)

  • 1. Apocrine lesions of the breast.
    Quinn CM; D'Arcy C; Wells C
    Virchows Arch; 2022 Jan; 480(1):177-189. PubMed ID: 34537861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.
    Celis JE; Moreira JM; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans V; Rank F
    Mol Oncol; 2007 Jun; 1(1):97-119. PubMed ID: 19383289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical Apocrine Adenosis: Diagnostic Challenges and Pitfalls.
    Asirvatham JR; Falcone MM; Kleer CG
    Arch Pathol Lab Med; 2016 Oct; 140(10):1045-51. PubMed ID: 27684975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apocrine lesions of the breast: part 1 of a two-part review: benign, atypical and in situ apocrine proliferations of the breast.
    D'Arcy C; Quinn C
    J Clin Pathol; 2019 Jan; 72(1):1-6. PubMed ID: 30409840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case.
    Visscher DW
    Arch Pathol Lab Med; 2009 Nov; 133(11):1817-21. PubMed ID: 19886717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast.
    D'Arcy C; Quinn CM
    J Clin Pathol; 2019 Jan; 72(1):7-11. PubMed ID: 30425121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.
    Seidman JD; Ashton M; Lefkowitz M
    Cancer; 1996 Jun; 77(12):2529-37. PubMed ID: 8640702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
    Elayat G; Selim AG; Wells CA
    Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apocrine Metaplasia Found at MR Biopsy: Is There Something to be Learned?
    Gao Y; Dialani V; DeBenedectis C; Johnson N; Brachtel E; Slanetz P
    Breast J; 2017 Jul; 23(4):429-435. PubMed ID: 28079289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
    Gatalica Z
    Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Histologic Spectrum of Apocrine Lesions of the Breast.
    Durham JR; Fechner RE
    Am J Clin Pathol; 2000 May; 113(suppl_1):S3-18. PubMed ID: 11993707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-operative breast pathology: apocrine lesions.
    Wells CA; El-Ayat GA
    J Clin Pathol; 2007 Dec; 60(12):1313-20. PubMed ID: 18042688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical follow-up results for apocrine adenosis and atypical apocrine adenosis diagnosed on breast core biopsy.
    Hou Y; Chaudhary S; Gao FF; Li Z
    Ann Diagn Pathol; 2016 Oct; 24():4-6. PubMed ID: 27649945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed Invasive Apocrine Papillary/Micropapillary Carcinoma of the Breast: Another Brick in the Triple-Negative Wall.
    Cima L; Mirabassi N; Sartori C; Carbone FG; Morelli L; Cserni G; Barbareschi M
    Int J Surg Pathol; 2021 Jun; 29(4):420-426. PubMed ID: 32909476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extratumoral breast tissue in breast cancer patients: a multinational study of variations with age and country of residence in low- and high-risk countries. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Aaman TB; Stalsberg H; Thomas DB
    Int J Cancer; 1997 May; 71(3):333-9. PubMed ID: 9139863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients.
    Fuehrer N; Hartmann L; Degnim A; Allers T; Vierkant R; Frost M; Visscher D
    Arch Pathol Lab Med; 2012 Feb; 136(2):179-82. PubMed ID: 22288965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
    Kővári B; Báthori Á; Cserni G
    Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apocrine adenosis: a precursor of aggressive breast cancer?
    Wells CA; McGregor IL; Makunura CN; Yeomans P; Davies JD
    J Clin Pathol; 1995 Aug; 48(8):737-42. PubMed ID: 7560201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.